Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by اس أي لاباز-سانوفي ان فيfiledCriticalاس أي لاباز-سانوفي ان في
Priority to JO19811162ApriorityCriticalpatent/JO1162B1/en
Application grantedgrantedCritical
Publication of JO1162B1publicationCriticalpatent/JO1162B1/en
Novel indolizine derivatives represented by the general formula And the pharmaceutically acceptable acid addition salts thereof, wherein R represents an alkyl radical having from 1 to 8 carbon atoms, or a phenyl group non-substituted or bearing one or two substituents, selected from halogen atoms and from lower alkyl and alkoxy groups X1 represents hydrogen, chlorine, bromine, iodine, methyl or methoxy A represents a group selected from In which X2 represents hydrogen, chlorine, bromine, iodine, methyl or methoxy and X3 represents hydrogen, chlorine, bromine, iodine or methyl, R1 represents a methyl, ethyl, n-butyl radical N represents an integer in the range of 2 to 6 inclusive With the proviso that when both X2 and X3 represent hydrogen or methyl, X1 is other than hydrogen They are effective for treating pathological syndromes of the heart and particularly angina pectoris and cardiac arrhythmias.
JO19811162A1981-03-241981-03-24Novel indolizine derivatives and process for preparing the same
JO1162B1
(en)
2%-Deoxy-3%,5%-di-O- alkylcarbonyl-5-fluorouridine derivatives, a process for the preparation of the derivatives and anti-tumor agents containing the derivatives